中文
|
English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Home
About Journal
Journal Introduction
Editorial Board
Reviewers
Style of Editorial Department
Advertising Policies
Submission Guideline
Instructions for Authors
Editorial Policies
Open Access Policy
Publishing Ethics
Publication Process Flow
Peer Review Process
Conflict of interest statement
Statement of Human and Animal Rights
Statement of Informed Consent and ethical approval
Data Sharing Policy
Statement of Copyright information
Open Science Identifier (OSID) Recording
Paper Template
Handling method for withdrawal
Journal Online
Online First
Current Issue
Archive
F5000 Articles
Hepatobiliary College
Guide to foreign journals
Industry information
Video Classroom
Guidelines
All Guidelines
Domestic guidelines
Foreign guidelines
Guideline translation
Guideline interpretation
Menu
All
Title
Author
Keyword
Abstract
DOI
Category
Address
Fund
Home
About Journal
Journal Introduction
Editorial Board
Reviewers
Style of Editorial Department
Advertising Policies
Submission Guideline
Instructions for Authors
Editorial Policies
Open Access Policy
Publishing Ethics
Publication Process Flow
Peer Review Process
Conflict of interest statement
Statement of Human and Animal Rights
Statement of Informed Consent and ethical approval
Data Sharing Policy
Statement of Copyright information
Open Science Identifier (OSID) Recording
Paper Template
Handling method for withdrawal
Journal Online
Online First
Current Issue
Archive
F5000 Articles
Hepatobiliary College
Guide to foreign journals
Industry information
Video Classroom
Guidelines
All Guidelines
Domestic guidelines
Foreign guidelines
Guideline translation
Guideline interpretation
PDF
Cite
Share
facebook
twitter
google
linkedin
All
Title
Author
Keyword
Abstract
DOI
Category
Address
Fund
Volume 39
Issue 5
May 2023
Turn off MathJax
Article Contents
References
Article Navigation
>
Journal of Clinical Hepatology
>
2023
>
39(5): 1171-1171
PDF
( 862 KB)
Hepatology Research
|Clinical features of chronic hepatitis B patients with lean nonalcoholic fatty liver disease
DOI:
10.3969/j.issn.1001-5256.2023.05.gwjpwzjj3
Published Date:
2023-05-20
Abstract
FullText(HTML)
References
(0)
References
Relative Articles
Relative Articles
[1]
Shihua HE, Lu DAI, Jie ZHENG, Chuanghong WU, Guoxin HU.
Therapeutic effect of low-carbohydrate diet and lifestyle intervention on patients with lean nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2024, 40(5): 946-951.
doi:
10.12449/JCH240513
[2]
Xiaoyan CHEN, Yifu YUAN, Shengnan DU, Qin CAO, Yuanye JIANG.
Clinical features and serum lipidomic profile of patients with nonalcoholic fatty liver disease and healthy individuals in the overweight population
[J]. Journal of Clinical Hepatology, 2024, 40(2): 284-291.
doi:
10.12449/JCH240211
[3]
Journal of Hepatology
|Development and validation of a prognostic model for 90-day survival in patients with alcohol-associated cirrhosis and acute decompensation
[J]. Journal of Clinical Hepatology, 2024, 40(3): 520-520.
doi:
10.12449/JCH2403.gwqkjpwzjj2
[4]
Journal of Gastroenterology and Hepatology
|Farnesoid X receptor is an important target for the treatment of disorders of bile acid and fatty acid metabolism in mice with nonalcoholic fatty liver disease combined with cholestasis
[J]. Journal of Clinical Hepatology, 2023, 39(11): 2523-2523.
doi:
10.3969/j.issn.1001-5256.2023.11.gwjpwzjj1
[5]
Hepatology International
|A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort study
[J]. Journal of Clinical Hepatology, 2023, 39(12): 2941-2941.
doi:
10.3969/j.issn.1001-5256.2023.12.gwjpwzjj2
[6]
Yujuan ZHANG, Xiqiao ZHOU.
Research advances in lean nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2023, 39(12): 2914-2919.
doi:
10.3969/j.issn.1001-5256.2023.12.024
[7]
Hepatology
|Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2022, 38(9): 2039-2039.
doi:
10.3969/j.issn.1001-5256.2022.09.gwjpwzjj3
[8]
Hepatology Research
|Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients
[J]. Journal of Clinical Hepatology, 2022, 38(6): 1228-1228.
doi:
10.3969/j.issn.1001-5256.2022.06.gwjpwzjj1
[9]
Hepatology
|Gastrodin improves nonalcoholic steatohepatitis by activating the AMPK signaling pathway
[J]. Journal of Clinical Hepatology, 2022, 38(2): 319-319.
doi:
10.3969/j.issn.1001-5256.2022.02.gwjpwzjj2
[10]
A RuHan, Jia HaiYan, Ding YanHua, Niu JunQi.
Research advances in nonalcoholic fatty liver disease in lean individuals
[J]. Journal of Clinical Hepatology, 2020, 36(5): 1154-1159.
doi:
10.3969/j.issn.1001-5256.2020.05.046
[11]
Zhang Dan, Feng GuoHe.
Current research status of nosocomial infection in patients with severe liver diseases
[J]. Journal of Clinical Hepatology, 2019, 35(1): 213-216.
doi:
10.3969/j.issn.1001-5256.2019.01.047
[12]
He ShiHua, Hu GuoXin.
Current status of the research on psychosocial factors in patients with nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2019, 35(8): 1861-1864.
doi:
10.3969/j.issn.1001-5256.2019.08.048
[13]
Chen YanZhen, Chen ChengLiang, Hong Yu, Wang Guan, Jiao Jian.
Research advances in the pathogenesis and risk factors of non-obese non-alcoholic fatty liver fibrosis and liver cirrhosis
[J]. Journal of Clinical Hepatology, 2018, 34(10): 2227-2231.
doi:
10.3969/j.issn.1001-5256.2018.10.037
[14]
Cao Dan, Chen WenJing, Li YanPing, Chen YanPing.
Research advances in chronic hepatitis B complicated by nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2018, 34(9): 1986-1989.
doi:
10.3969/j.issn.1001-5256.2018.09.033
[15]
Liu LuLu, Ren Yi, He YiHuai, Lin ShiDe.
Research advances in chronic hepatitis B complicated by nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2017, 33(3): 538-542.
doi:
10.3969/j.issn.1001-5256.2017.03.032
[16]
Zhang ZhiQiao, Wang GongSui, Kang KaiFu, Wu GuoBiao, Wang Peng.
Prevalence and clinical features of hepatic steatosis in patients with chronic hepatitis B
[J]. Journal of Clinical Hepatology, 2015, 31(7): 1063-1067.
doi:
10.3969/j.issn.1001-5256.2015.07.016
[17]
Ying RuoSu, Chen YanYu, Zhuo Li, Fan HuiMin, Yang Zhan.
Therapeutic effect of antiviral therapy in chronic hepatitis B patients with nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2013, 29(8): 603-606.
doi:
10.3969/j.issn.1001-5256.2013.08.013
[18]
Wang Zi, Hu DaoYu.
Research advances in quantitative evaluation of liver fat in patients with nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2013, 29(12): 894-896.
doi:
10.3969/j.issn.1001-5256.2013.12.005
[19]
Wu Tao, Yin ShouYi, Wang HongZhang, Zhang Hong, Jia Wei, Ji Guang.
The clinical features and risk factors of patient with metabolic syndrome combined with non-alcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2011, 27(10): 1036-1040.
[20]
Li Lei, Ding HuiGuo.
Clinical features of cirrhosis due to nonalcoholic steatohepatitis
[J]. Journal of Clinical Hepatology, 2011, 27(10): 1032-1035.
Supplements
(0)
Cited By
Proportional views
Proportional views
Catalog
通讯作者:
陈斌, bchen63@163.com
1.
沈阳化工大学材料科学与工程学院 沈阳 110142
本站搜索
百度学术搜索
万方数据库搜索
CNKI搜索
Get Citation
PDF
XML
Article Metrics
Article views (
257
)
PDF downloads(
30
)
Cited by(
)
Proportional views
Related
Previous
Next
×
Close
Export File
Citation
Hepatology Research|Clinical features of chronic hepatitis B patients with lean nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2023, 39(5): 1171-1171. DOI: 10.3969/j.issn.1001-5256.2023.05.gwjpwzjj3.
Hepatology Research
|Clinical features of chronic hepatitis B patients with lean nonalcoholic fatty liver disease[J].
J Clin Hepatol
, 2023, 39(5): 1171-1171.
DOI:
10.3969/j.issn.1001-5256.2023.05.gwjpwzjj3.
Format
RIS(for EndNote,Reference Manager,ProCite)
BibTex
Txt
Content
Citation Only
Citation and Abstract
/
DownLoad:
Full-Size Img
PowerPoint
Return
Return